Literature DB >> 16236602

Early endotoxin-mediated haemostatic and inflammatory responses in the clopidogrel-treated pig.

Miklós Lipcsey1, Anders Larsson, Matts Olovsson, Jan Sjölin, Mats B Eriksson.   

Abstract

We have previously shown that the thrombin inhibiting agent melagatran markedly prolongs aPTT and counteracts creatinine increase in endotoxemic pigs. Against this background the effects of the platelet-inhibiting agent, clopidogrel on basic haemostatic, inflammatory and physiological variables were evaluated during porcine endotoxemia. Clopidogrel (10 mg/kg) or saline was randomly injected i.v. 30 min before start of a 6-h continuous infusion of endotoxin in 12 anaesthetised pigs. Another three pigs were given clopidogrel but not endotoxin. Clopidogrel did not affect physiological variables, formation of activated platelet microparticles, PK, aPTT, platelet count, plasma fibrinogen, TNF-alpha, or IL-6 during porcine endotoxemia. Although renal function, as evaluated by creatinine clearance (CLcr) deteriorated significantly (P = 0.01) in the saline-endotoxin, but not in the clopidogrel-endotoxin group, there was no significant difference between the saline-endotoxin and the clopidogrel-endotoxin groups. Renal biopsies were marked with a FITC-labelled chicken anti-fibrinogen antibody detecting fibrinogen and platelet bound fibrinogen, as a marker of porcine platelet activation, and examined by light microscopy. Evaluation of these immunohistochemical slides did not indicate that clopidogrel, significantly reduced the amount of intrarenal fibrin or fibrinogen depositions. Besides a trend to preserve renal function, clopidogrel did not affect haemodynamics or the coagulatory and inflammatory responses in porcine endotoxemia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16236602     DOI: 10.1080/09537100500163168

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  8 in total

Review 1.  Platelets as immune mediators: their role in host defense responses and sepsis.

Authors:  Zhenyu Li; Fanmuyi Yang; Steve Dunn; A Kendall Gross; Susan S Smyth
Journal:  Thromb Res       Date:  2010-11-13       Impact factor: 3.944

Review 2.  Microvesicles at the crossroads between infection and cardiovascular diseases.

Authors:  Jing Xiong; Virginia M Miller; Yunman Li; Muthuvel Jayachandran
Journal:  J Cardiovasc Pharmacol       Date:  2012-02       Impact factor: 3.105

3.  Thrombocytopenia impairs host defense in gram-negative pneumonia-derived sepsis in mice.

Authors:  Sacha F de Stoppelaar; Cornelis van 't Veer; Theodora A M Claushuis; Bregje J A Albersen; Joris J T H Roelofs; Tom van der Poll
Journal:  Blood       Date:  2014-10-09       Impact factor: 22.113

4.  Platelet P2Y12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model.

Authors:  Mark R Thomas; Samuel N Outteridge; Ramzi A Ajjan; Fladia Phoenix; Gurpreet K Sangha; Rachael E Faulkner; Rosemary Ecob; Heather M Judge; Haroon Khan; Laura E West; David H Dockrell; Ian Sabroe; Robert F Storey
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-10-29       Impact factor: 8.311

5.  Beneficial effects of combined administration of Clopidogrel and Aspirin on the levels of proinflammatory cytokines, cardiac function, and prognosis in ST-segment elevation myocardial infarction: A comparative study.

Authors:  Hai-Rong Yu; Yue-Yue Wei; Jian-Guo Ma; Xiao-Yong Geng
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

6.  Beyond thrombosis: the versatile platelet in critical illness.

Authors:  Jason N Katz; Kamalkumar P Kolappa; Richard C Becker
Journal:  Chest       Date:  2011-03       Impact factor: 9.410

7.  Platelets induce apoptosis during sepsis in a contact-dependent manner that is inhibited by GPIIb/IIIa blockade.

Authors:  Matthew Sharron; Claire E Hoptay; Andrew A Wiles; Lindsay M Garvin; Mayya Geha; Angela S Benton; Kanneboyina Nagaraju; Robert J Freishtat
Journal:  PLoS One       Date:  2012-07-26       Impact factor: 3.240

8.  Outcomes of severe sepsis and septic shock patients on chronic antiplatelet treatment: a historical cohort study.

Authors:  Juan C Valerio-Rojas; Insara J Jaffer; Daryl J Kor; Ognjen Gajic; Rodrigo Cartin-Ceba
Journal:  Crit Care Res Pract       Date:  2013-02-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.